Literature DB >> 2898128

A HindIII RFLP demonstrated for the kit oncogene on chromosome 4.

L D Berdahl1, J C Murray, P Besmer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898128      PMCID: PMC336679          DOI: 10.1093/nar/16.10.4740

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  2 in total

1.  A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family.

Authors:  P Besmer; J E Murphy; P C George; F H Qiu; P J Bergold; L Lederman; H W Snyder; D Brodeur; E E Zuckerman; W D Hardy
Journal:  Nature       Date:  1986 Apr 3-9       Impact factor: 49.962

2.  Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

Authors:  Y Yarden; W J Kuang; T Yang-Feng; L Coussens; S Munemitsu; T J Dull; E Chen; J Schlessinger; U Francke; A Ullrich
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

  2 in total
  4 in total

1.  TaqI RFLP at the c-kit oncogene locus (KIT).

Authors:  R A Drachtman; E N Geissler; B P Alter
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

2.  A detailed multipoint map of human chromosome 4 provides evidence for linkage heterogeneity and position-specific recombination rates.

Authors:  K H Buetow; R Shiang; P Yang; Y Nakamura; G M Lathrop; R White; J J Wasmuth; S Wood; L D Berdahl; N J Leysens
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

3.  An SstI RFLP at the C-Kit oncogene locus (KIT).

Authors:  D Curtis
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

4.  Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism.

Authors:  R A Spritz; S A Holmes; R Ramesar; J Greenberg; D Curtis; P Beighton
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.